Literature DB >> 20551694

Socioeconomic trends in hospitalization for multiple sclerosis.

Shivanand P Lad1, Christopher H Chapman, Michael Vaninetti, Lawrence Steinman, Ari Green, Maxwell Boakye.   

Abstract

OBJECTIVES: Multiple sclerosis (MS) is a neurological disorder with a high burden on patient quality of life and medical rehabilitation services. Little is known about the acute hospitalization costs and characteristics. We examined the trends in MS hospitalizations from 1993 to 2006.
METHODS: The Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project was searched using the ICD-9 code 340 (MS). Diagnostic, treatment and administrative data were analyzed using basic statistical software.
RESULTS: A total of 288,454 hospital admissions with the primary diagnosis of MS occurred between 1993 and 2006, an average of 20,604 admissions annually. The percentage admitted from the emergency department (ED) increased from 19.4 to 60.0% during 1993-2006. The mean cost for each inpatient increased from USD 7,965 to 20,076. The percentage of discharges to home health care increased from 8.6 to 14.9%, and the percentage of discharges to nursing homes and rehabilitation services increased from 8.3 to 22.6%. In 2006, Medicaid patients were significantly more likely to be admitted from the ED (p < 0.001). Medicare payers were significantly more likely to be discharged to a nursing home/rehabilitation (p < 0.0001).
CONCLUSION: National health insurance policies have made measurable effects on MS disease management. MS is becoming more expensive to treat acutely, and improved treatment modalities geared toward decreasing acute flare-ups may provide substantial cost savings by reducing ED visits, inpatient hospitalizations and the need for rehabilitation. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20551694     DOI: 10.1159/000310301

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  11 in total

1.  Teriflunomide in relapsing multiple sclerosis: therapeutic utility.

Authors:  Mark S Freedman
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Comorbidity increases the risk of hospitalizations in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

3.  Multiple Sclerosis Wellness Shared Medical Appointment Model: A Pilot Study.

Authors:  Justin R Abbatemarco; Jeffrey A Cohen; Belinda L Udeh; Sunakshi Bassi; Mary R Rensel
Journal:  Int J MS Care       Date:  2021-04-08

4.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

5.  Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients.

Authors:  Michalina Rzepka; Mateusz Toś; Michał Boroń; Katarzyna Gibas; Ewa Krzystanek
Journal:  Medicina (Kaunas)       Date:  2020-12-21       Impact factor: 2.430

6.  Do Hungarian multiple sclerosis care units fulfil international criteria?

Authors:  Zsófia Kokas; Dániel Sandi; Zsanett Fricska-Nagy; Judit Füvesi; Tamás Biernacki; Ágnes Köves; Ferenc Fazekas; Adrienne Jóri Birkás; Gabriella Katona; Krisztina Kovács; Dániel Milanovich; Enikő Dobos; István Kapás; Gábor Jakab; Tünde Csépány; Erzsébet Bense; Klotild Mátyás; Gábor Rum; Zoltán Szolnoki; István Deme; Zita Jobbágy; Dávid Kriston; Zsuzsanna Gerócs; Péter Diószeghy; László Bors; Adrián Varga; Levente Kerényi; Gabriella Molnár; Piroska Kristóf; Zsuzsanna Ágnes Nagy; Mária Sátori; Piroska Imre; Szilvia Péntek; Péter Klivényi; Zsigmond Tamás Kincses; László Vécsei; Krisztina Bencsik
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

7.  Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement.

Authors:  Hesham Abboud; Karin Mente; Meagan Seay; Jeffrey Kim; Ashhar Ali; Robert Bermel; Mary A Willis
Journal:  Int J MS Care       Date:  2017 Nov-Dec

8.  Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.

Authors:  Waldemar Brola; Piotr Sobolewski; Stanisław Flaga; Małgorzata Fudala; Wiktor Szczuchniak; Jan Stoiński; Anita Rosołowska; Jacek Wójcik; Katarzyna Kapica-Topczewska; Danuta Ryglewicz
Journal:  BMC Neurol       Date:  2016-08-11       Impact factor: 2.474

9.  Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.

Authors:  Guilherme Silva Julian; Ricardo Papaléo Rosim; Estela Cristina Carneseca; Jéssica Rigolon
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

10.  Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis.

Authors:  Ewa Krzystanek; Agata Jurczak; Kinga Kocur; Jakub Jurkiewicz; Aleksandra Kaczmarczyk
Journal:  Int J Environ Res Public Health       Date:  2022-03-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.